Brivaracetam
| CAS No. | 357336-20-0 |
|---|---|
| MDL No. | MFCD25976668 |
| MF | C11H20N2O2 |
| MW | 212.29 |
| InChI Key | MSYKRHVOOPPJKU-BDAKNGLRSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Brivaracetam is a non-proteinogenic amino acid derivative, a gamma-lactam, and an anticonvulsant used to treat partial onset seizures in epilepsy. It is a butanamide with the pro-S hydrogen at position 2 replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl group. It is functionally related to L-alpha-aminobutyric acid.
| CAS No. | 357336-20-0 |
|---|---|
| Product Name | Brivaracetam |
Biological Targets
SV2A
Associated Conditions
Unverricht-Lundborg disease·juvenile absence epilepsy·childhood absence epilepsy·brain neoplasm·epilepsy·
* The information provided here is compiled from public sources and is for reference only.
